CareerPlanSign in

US Medical Head, Early Assets

US - Wilmington - DE💼 Full-time💰 $331,874–$331,874🗓 2026-09-22 → 2026-09-26

Core

Lead US medical strategy for early pipeline assets, shaping novel therapy development and ensuring US perspectives in global plans.

Role type

Senior medical strategy leader (early assets)

Builds

Early pipeline therapies and scientific narratives for US market access and labeling

Domain

Pharmaceuticals (CV and metabolism, obesity/weight management)

Deliverable

production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work

Required skills

Strategic leadership in complex matrix, translational medicine planning, US regulatory strategy, evidence generation, external network building, study design expertise

Preferred skills

Immunology/cell therapy knowledge, global R&D experience, marketing/R&D/market access background

Technologies

Clinical trial platforms, real-world evidence tools

Responsibilities

Lead US medical strategy for early pipeline assets, develop translational and early clinical development plans, guide study design elements, build external engagement plans, champion evidence generation activities, influence cross-functional decision-making

Seniority

Senior, hands-on IC with strategic scope

Sourced via workday · Listed on CareerPlan, which tracks 70,000+ jobs from 20+ sources.